The first two drugs showing promise in slowing the progression of geographic atrophy are poised for FDA approval. Will this signal a new era in patient care?
The February supplement from the USC Roski Eye Institute can be found here: 2022 Annual Report.
Advertisement
DETECT THE HIDDEN DANGER OF THYROID EYE DISEASE (TED)
![TEDimpact_logo2.png](https://d31g6oeq0bzej7.cloudfront.net/Assets/image/webp/db468fb4-b937-4ada-bddb-f1460e0f4245.webp)
© 2022 Horizon Therapeutics plc DA-UNBR-US-01273 12/22
|